The National Forum for Heart Disease & Stroke Prevention announced the launch of the Stronger Hearts Helpline, a 24/7 free call-center resource for people with heart failure and their families. The pilot program is an addition to the existing 2-1-1 information and referral hotline in San Bernardino County, California – a region where nearly 20 percent of Medicare recipients are being treated for heart failure – and long-term plans are to expand the service nationwide.

Americans are ready and willing to leverage health apps and wearable devices to improve their personal health, according to the findings released from the fifth annual Makovsky/Kelton "Pulse of Online Health" Survey.

Medtronic announced that the U.S. Centers for Medicare and Medicaid Services (CMS) has approved a transitional pass-through payment for the company’s IN.PACT Admiral drug-coated balloon (DCB) under the Medicare hospital outpatient prospective payment system (OPPS). The decision removes a potential barrier to patient access to this new medical device, which represents an improvement to the standard of care for peripheral arterial disease in the upper leg.

C. R. Bard Inc. announced that the U.S. Centers for Medicare and Medicaid Services (CMS) has approved a pass-through payment for the Lutonix drug-coated balloon (DCB) under the Medicare hospital outpatient prospective payment system. This approval follows a unanimous favorable recommendation from the U.S. Food and Drug Administration’s (FDA) Circulatory Systems Devices Advisory Panel.

Pie Medical Imaging BV announced that it received 510(k) clearance from the U.S. Food and Drug Administration for its CAAS A-Valve product including the quantitative Regurgitation Analysis (qRA) workflow. The qRA workflow is the first 510(k) cleared image analysis technology to determine aortic regurgitation based on X-ray angiography.

Medtronic's Attain Performa Quadripolar Lead and VivaQuad XT CRT-D system. Quadripolar leads enable more programming options to enable better patient care with this implantable cardioverter defibillator (ICD)..
S-ICD, Boston Scientific, subcutaneous ICD, ICD, implantable cardioverter defibrillator
Boston Scientific, Incepta, Energen, Punctua, ICD, ICD, implantable cardioverter defibrillator
ICD, implantable cardioverter defibrillator, quadripolar leads

There have been several recent advancements in implantable cardioverter defibrillator (ICD) technology to extend battery life, improvements in patient monitoring to avoid needless shocks, the introduction of quadripolar lead devices to improve device programming and to improve therapy effectiveness, and development of MRI-safe ICDs. 
Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now